| Ex-Date | Pay Date | Amount | Change |
|---|---|---|---|
| CN¥0.03 | -40% | ||
| CN¥0.03 | -40% | ||
| CN¥0.05 | 400% | ||
| CN¥0.05 | 400% | ||
| CN¥0.01 | 0% | ||
| CN¥0.01 | -50% | ||
| CN¥0.02 | 0% | ||
| CN¥0.02 | -60% | ||
| CN¥0.05 | 66.67% | ||
| CN¥0.03 | 200% | ||
| CN¥0.01 | 0% | ||
| CN¥0.01 | -66.67% | ||
| CN¥0.03 | |||
Hunan Er-Kang Pharmaceutical Co Ltd Class A pays a dividend yield (FWD) of 1.33%.
- ISIN
- WKN
- -
- Symbol / Exchange
- / XSHE
- Value
- €0.40
- Dividend frequency
- annually
- Security Type
- Equity
- Sector
Health Care
- Country
China
- Dividend Currency
- Chinese Yuan
- Within the last 12 months, Hunan Er-Kang Pharmaceutical Co Ltd Class A paid a dividend of CN¥0.00. For the next 12 months, Hunan Er-Kang Pharmaceutical Co Ltd Class A is expected to pay a dividend of CN¥0.03. This corresponds to a dividend yield of approximately 1.33%.
- The dividend yield of Hunan Er-Kang Pharmaceutical Co Ltd Class A is currently 1.33%.
- Hunan Er-Kang Pharmaceutical Co Ltd Class A pays annually dividends. Payout is in June.
- The next dividend for Hunan Er-Kang Pharmaceutical Co Ltd Class A is expected in June.
- Within the last 10 years, Hunan Er-Kang Pharmaceutical Co Ltd Class A has paid dividends in 8 of them.
- Dividends of CN¥0.03 are expected for the next 12 months. This corresponds to a dividend yield of 1.33%.
- Hunan Er-Kang Pharmaceutical Co Ltd Class A is assigned to the sector "Health Care".
- The last stock split of Hunan Er-Kang Pharmaceutical Co Ltd Class A was on 10 May 2016 in the ratio 20:10.
- To receive the last dividend of Hunan Er-Kang Pharmaceutical Co Ltd Class A on 9 June 2023 in the amount of CN¥0.03 you had to have the stock in your portfolio before the ex-day on 9 June 2023.
- The last dividend was paid on 9 June 2023.
- In 2022, no dividends were paid by Hunan Er-Kang Pharmaceutical Co Ltd Class A.
- Dividends from Hunan Er-Kang Pharmaceutical Co Ltd Class A are paid in Chinese Yuan.
- The headquarters of Hunan Er-Kang Pharmaceutical Co Ltd Class A is located in China.